title: Metabolic, hepatic and muscular changes during zidovudine therapy: a drug-induced mitochondrial disease?
authors.forename: P
authors.initials: P
authors.lastname: Le Bras
authors.forename: R
authors.initials: R
authors.lastname: D'Oiron
authors.forename: Y
authors.initials: Y
authors.lastname: Quertainmont
authors.forename: P
authors.initials: P
authors.lastname: Halfon
authors.forename: R
authors.initials: R
authors.lastname: Caquet
mesh_terms: D000140:Acidosis, Lactic / Q000139:chemically induced*; D000328:Adult; D004258:DNA Polymerase III / Q000037:antagonists & inhibitors; D004261:DNA Replication / Q000187:drug effects; D004272:DNA, Mitochondrial / Q000096:biosynthesis; D005234:Fatty Liver / Q000139:chemically induced*; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D006467:Hemophilia A / Q000150:complications; D006529:Hepatomegaly / Q000139:chemically induced; D006801:Humans; D008297:Male; D017240:Mitochondrial Myopathies / Q000139:chemically induced*; D015215:Zidovudine / Q000009:adverse effects* / Q000494:pharmacology
chemical_list: D004272:DNA, Mitochondrial; D015215:Zidovudine; D004258:DNA Polymerase III